These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion. de Baere T; Deschamps F; Briggs P; Dromain C; Boige V; Hechelhammer L; Abdel-Rehim M; Aupérin A; Goere D; Elias D Radiology; 2008 Sep; 248(3):1056-66. PubMed ID: 18632532 [TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors. Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Hess A; Palussière J; Goyers JF; Guth A; Aupérin A; de Baère T Radiology; 2011 Feb; 258(2):635-42. PubMed ID: 21273525 [TBL] [Abstract][Full Text] [Related]
12. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679 [TBL] [Abstract][Full Text] [Related]
13. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Deandreis D; Leboulleux S; Dromain C; Auperin A; Coulot J; Lumbroso J; Deschamps F; Rao P; Schlumberger M; de Baère T Radiology; 2011 Jan; 258(1):270-6. PubMed ID: 21045185 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. de Baere T; Bessoud B; Dromain C; Ducreux M; Boige V; Lassau N; Smayra T; Girish BV; Roche A; Elias D AJR Am J Roentgenol; 2002 Jan; 178(1):53-9. PubMed ID: 11756087 [TBL] [Abstract][Full Text] [Related]
15. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma. Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Lee JM; Jin GY; Goldberg SN; Lee YC; Chung GH; Han YM; Lee SY; Kim CS Radiology; 2004 Jan; 230(1):125-34. PubMed ID: 14645875 [TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients. VanSonnenberg E; Shankar S; Morrison PR; Nair RT; Silverman SG; Jaklitsch MT; Liu F; Cheung L; Tuncali K; Skarin AT; Sugarbaker DJ AJR Am J Roentgenol; 2005 Feb; 184(2):381-90. PubMed ID: 15671350 [TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device. Laganà D; Carrafiello G; Mangini M; Boni L; Dionigi G; Fusi MC; Cinquepalmi L; Rovera F; Cuffari S; Fugazzola C Surg Endosc; 2006 Aug; 20(8):1262-7. PubMed ID: 16858532 [TBL] [Abstract][Full Text] [Related]